Memorandum of Understanding (MoU) with leading Indonesian biomedical company PT Etana Biotechnologies MoU aims to facilitate late-stage clinical trials in Indonesia, supporting the Indonesian ...
RECCE ® 327 Topical Gel (R327G) was demonstrated to be safe and well-tolerated in patients – R327G demonstrating highly encouraging efficacy results as determined by non-Data Safety Monitoring Board ...
Over the last year, a good number of insiders have significantly increased their holdings in Recce Pharmaceuticals Ltd (ASX:RCE). This is encouraging because it indicates that insiders are more ...
Hosted on MSN
Recce Pharmaceuticals secures A$85 million R&D tax incentive for global anti-infective programs
Recce Pharmaceuticals Ltd. ( (AU:RCE)) has shared an update. Recce Pharmaceuticals has been awarded an Advanced Overseas Finding for up to A$85 million by the Australian Government, which extends the ...
To get a sense of who is truly in control of Recce Pharmaceuticals Ltd (ASX:RCE), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's ...
Phase 1/2 trial of RECCE ® 327 (R327) is approved to start at the South West Sydney Limb Preservation and Wound Research Unit, located at the Ingham Institute of Medical Research Study will assess the ...
Hosted on MSN
Recce’s anti-infective topical gel fights hard against tough antibiotic-resistant burn wounds
Recce’s R327G highly effective against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa infected wounds (in-vivo) R327G efficacy outcomes statistically significant and ...
India's federal government kept a tight leash on spending in its annual budget for 2026-27, as income and consumption tax cuts announced in the past year weighed on revenues. Reuters, the news and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results